摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,1,4,4-四(4-氯苯基)丁-1,2,3-三烯 | 64434-53-3

中文名称
1,1,4,4-四(4-氯苯基)丁-1,2,3-三烯
中文别名
——
英文名称
1,1,4,4-tetrakis(4-chlorophenyl)buta-1,2,3-triene
英文别名
tetrakis-(4-chloro-phenyl)-butatriene;Tetrakis-(4-chlor-phenyl)-butatrien;1,1,4,4-Tetra-(p-chlorphenyl)-butatrien
1,1,4,4-四(4-氯苯基)丁-1,2,3-三烯化学式
CAS
64434-53-3
化学式
C28H16Cl4
mdl
——
分子量
494.247
InChiKey
FFHBSTNNFKWUBY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    294-298 °C (decomp)
  • 沸点:
    687.4±55.0 °C(Predicted)
  • 密度:
    1.288±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    9.7
  • 重原子数:
    32
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1,1,4,4-四(4-氯苯基)丁-1,2,3-三烯盐酸溶剂黄146 作用下, 生成 6-chloro-3-(4-chloro-phenyl)-1-(4,4'-dichloro-benzhydrylidene)-indene
    参考文献:
    名称:
    In vitro antimicrobial susceptibilities of three Porphyromonas spp and in vivo responses in the oral cavity of cats to selected antimicrobial agents
    摘要:
    ObjectivesTo determine in vitro susceptibility ofPorphyromonas gingivalis, P salivosaandP circumdentariato seven antimicrobial agents by agar dilution and Epsilometer test methods and to assess the effectiveness of these antimicrobial agents in reducing the numbers of eachPorphyromonasspp in the oral cavity of 16 domestic cats.DesignA two‐part prospective study involving in vitro antimicro‐bial studies usingPorphyromonasspp obtained from naturally occurring feline infections and in vivo antimicrobial response studies using client‐owned cats with naturally occurring periodontal disease.ProcedureIsolates (n = 25) of three felinePorphyromonasspp from the oral cavity and oral‐associated disease were tested for their in vitro susceptibility to amoxycillin, amoxycillin‐clavulanate, benzylpenicillin, clindamycin, doxycycline, erythromycin and metronidazole, using agar dilution and Epsilometer test methods. Digoxigenin‐labelled whole chromosomal DNA probes directed againstP gingivalis VPB3492,P circumdentariaNCTC 12469TandP salivosaVPB 3313 were used to quantify organisms taken from two sample sites at the gingival margins of these cats prior to, and 5 days after, treatment with one of four commonly used antimicrobial products (amoxycillin‐clavulanate, clindamycin, doxycycline or spiramycin‐metronidazole). The response to treatment was assessed clinically for each cat.ResultsAll isolates were susceptible in vitro to all seven antimicrobial agents using both methods. The numbers ofP gingivaliswere not reduced at the gingival sample sites by administration of amoxycillin‐clavulanate for 5 days, although this treatment reduced the numbers ofP salivosaandP circumdentaria tobelow detection levels in six of eight and two of three of sample sites, respectively; clinical improvement was not observed in cats treated with amoxycillin‐clavulanate. Treatment with clindamycin, doxycycline or spiramycin‐metronidazole resulted in clinical improvement and a marked reduction of allPorphyromonasisolates at the sample sites.ConclusionThe Epsilometer test is a simple and accurate method for determining the minimum inhibitory concentration forP gingivalis, P salivosaandP circumdentaria.All strains were susceptible in vitro to all the antimicrobial agents tested, although clinical improvement of gingival disease was not noted with amoxycillin‐clavulanate when given for 5 days at usual doses. This appears to be the first report of the disparity between the in vivo and in vitro susceptibility of oral bacterial strains to amoxycillin‐clavulanate in the veterinary dental literature. This also appears to be the first report in which clinical and microbiological responses to commonly used antimicrobial agents for periodontal disease in cats has been documented and quantified. It was shown that treatment with clindamycin, spiramycin‐metronidazole or doxycycline not only produced a substantial reduction in the number ofPorphyromonasspp (in the majority of cases to below detection levels), but also resulted in substantial clinical improvement. This would indicate that these antimicrobial agents are useful adjunctive therapy to mechanical debridement in domestic cats.
    DOI:
    10.1111/j.1751-0813.2000.tb11895.x
  • 作为产物:
    描述:
    1,1'-(3-methoxyprop-1-yne-3,3-diyl)bis(4-chlorobenzene)盐酸正丁基锂 、 tin(ll) chloride 作用下, 以 四氢呋喃乙醚 为溶剂, 反应 19.0h, 生成 1,1,4,4-四(4-氯苯基)丁-1,2,3-三烯
    参考文献:
    名称:
    由四芳基[3]枯草酮合成氰基取代的二芳基四氢呋喃
    摘要:
    从易于获得的四芳基[3]枯草酮开始,已开发了一种通用的,两步合成高取代度,氰基官能化的二芳基四氢呋喃酮。这种前所未有的转变是由四氰基乙烯(TCNE)的[2 + 2]环加成到异丙苯的炔基中央双键上而产生的中间两性离子,在电环化级联和脱氢后,它会生成5,5,11,11-四氰基-一锅法中的5,11-二氢四氢呋喃。随后的铜辅助脱氰/芳构化提供了目标5,11-二氰基-6,12-二芳基并四苯衍生物。所有假定的结构均通过X射线晶体学确认。新的生色团具有极高的热稳定性,并具有前景广阔的荧光特性,可用于光电设备。与CN取代基之一配位并形成1:1络合物的I离子在298 K时的结合常数为K a = 1.5×10 5  L mol -1。
    DOI:
    10.1002/anie.201402299
点击查看最新优质反应信息

文献信息

  • Novel reactions of 1,1,4,4-tetraaryl-1,2,3-butatrienes with elemental sulfur and selenium
    作者:Norihiro Tokitoh、Hiroshi Hayakawa、Midori Goto、Wataru Ando
    DOI:10.1016/s0040-4039(00)82083-3
    日期:1988.1
    Sulfurization and selenation reactions of 1,1,4,4-tetraaryl-1,2,3-butatrienes were examined to give novel 1,2,3,4,5-pentathiepane and 1,2,5-triselenepane ring systems. Further degradation of these new heterocycles using DBU/DMF was also described.
    研究了1,1,4,4-四芳基-1,2,3-丁烯化和化反应,得到了新的1,2,3,4,5-戊戊二烯和1,2,5-三烯戊环体系。还描述了使用DBU / DMF对这些新杂环的进一步降解。
  • A Four-Step Synthesis of Substituted 5,11-Dicyano-6,12-diaryltetracenes with Enhanced Stability and High Fluorescence Emission
    作者:Nicolas Kerisit、Przemyslaw Gawel、Brian Levandowski、Yun-Fang Yang、Víctor García-López、Nils Trapp、Laurent Ruhlmann、Corinne Boudon、Kendall N. Houk、François Diederich
    DOI:10.1002/chem.201703903
    日期:2018.1.2
    A fourstep synthesis of substituted 5,11‐dicyano‐6,12‐diaryltetracenes was developed, starting from readily available para‐substituted benzophenones. The key step of this straightforward route is the complex cascade reaction between tetraaryl[3]cumulenes and tetracyanoethene (TCNE) resulting in 5,5,11,11‐tetracyano‐5,11‐dihydrotetracenes. The mechanism of this transformation was reinvestigated by
    从容易获得的对位取代的二苯甲酮开始,开发了一种四步合成取代的5,11-二基-6,12-二芳基四烯酮。这种简单方法的关键步骤是四芳基[3]枯烯四氰基乙烯(TCNE)之间的复杂级联反应,产生5,5,11,11-tetracyano-5,11-dihydrotetracenes。通过理论计算重新研究了这种转变的机理。通过Cu I或Cu II催化的新开发的脱/芳构化反应获得目标四碳原子。溶液中的配合物,可与各种官能团兼容的条件。计算机制研究为这种转变提供了启示。X射线晶体学证实了所有并四苯生物的结构。所提出的双四氢呋喃生物具有出色的光电性能和增强的光稳定性,大大超过了参考红荧烯(5,6,11,12-四苯基并四苯)。
  • Ando, Wataru; Tokitoh, Norihiro; Kabe, Yoshio, Phosphorus, Sulfur and Silicon and the Related Elements, 1991, vol. 58, # 1-4, p. 179 - 205
    作者:Ando, Wataru、Tokitoh, Norihiro、Kabe, Yoshio
    DOI:——
    日期:——
  • The Action of Ultraviolet Light on DDT
    作者:Elmer E. Fleck
    DOI:10.1021/ja01171a073
    日期:1949.3
  • Brand, Chemische Berichte, 1950, vol. 83, p. 346,353
    作者:Brand
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫